D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26%
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is 19 388.02 KRW. Compared to the current market price of 16 710 KRW, Dongkook Pharmaceutical Co Ltd is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
19 388.02 KRW
Undervaluation 14%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation History
Dongkook Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Dongkook Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Dongkook Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

16 710 KRW
+2.26%
+2.26%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Dongkook Pharmaceutical Co Ltd
KR
Pharmaceuticals
Market Cap
734.7B KRW
IPO
May 29, 2007
Employees
-
Korea
Market Cap
734.7B KRW
Industry
Pharmaceuticals
IPO
May 29, 2007
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Dongkook Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Dongkook Pharmaceutical Co Ltd.

What unique competitive advantages
does Dongkook Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Dongkook Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dongkook Pharmaceutical Co Ltd.

Provide P/S
for Dongkook Pharmaceutical Co Ltd.

Provide P/E
for Dongkook Pharmaceutical Co Ltd.

Provide P/OCF
for Dongkook Pharmaceutical Co Ltd.

Provide P/FCFE
for Dongkook Pharmaceutical Co Ltd.

Provide P/B
for Dongkook Pharmaceutical Co Ltd.

Provide EV/S
for Dongkook Pharmaceutical Co Ltd.

Provide EV/GP
for Dongkook Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Dongkook Pharmaceutical Co Ltd.

Provide EV/EBIT
for Dongkook Pharmaceutical Co Ltd.

Provide EV/OCF
for Dongkook Pharmaceutical Co Ltd.

Provide EV/FCFF
for Dongkook Pharmaceutical Co Ltd.

Provide EV/IC
for Dongkook Pharmaceutical Co Ltd.

Show me price targets
for Dongkook Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Dongkook Pharmaceutical Co Ltd?

What are the Net Income projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Dongkook Pharmaceutical Co Ltd?

What are the EPS projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Dongkook Pharmaceutical Co Ltd?

What are the EBIT projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Dongkook Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Dongkook Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dongkook Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dongkook Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dongkook Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Dongkook Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Dongkook Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Dongkook Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Dongkook Pharmaceutical Co Ltd.

Provide ROE
for Dongkook Pharmaceutical Co Ltd.

Provide ROA
for Dongkook Pharmaceutical Co Ltd.

Provide ROIC
for Dongkook Pharmaceutical Co Ltd.

Provide ROCE
for Dongkook Pharmaceutical Co Ltd.

Provide Gross Margin
for Dongkook Pharmaceutical Co Ltd.

Provide Operating Margin
for Dongkook Pharmaceutical Co Ltd.

Provide Net Margin
for Dongkook Pharmaceutical Co Ltd.

Provide FCF Margin
for Dongkook Pharmaceutical Co Ltd.

Show all solvency ratios
for Dongkook Pharmaceutical Co Ltd.

Provide D/E Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide D/A Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Quick Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Current Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Cash Ratio
for Dongkook Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Dongkook Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Dongkook Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Dongkook Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dongkook Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dongkook Pharmaceutical Co Ltd

Current Assets 481.2B
Cash & Short-Term Investments 87.2B
Receivables 214.9B
Other Current Assets 179.2B
Non-Current Assets 440B
Long-Term Investments 128.8B
PP&E 281.3B
Intangibles 19.1B
Other Non-Current Assets 10.7B
Current Liabilities 225.4B
Accounts Payable 92.7B
Accrued Liabilities 7.6B
Short-Term Debt 43.3B
Other Current Liabilities 81.8B
Non-Current Liabilities 118.2B
Long-Term Debt 28.4B
Other Non-Current Liabilities 89.8B
Efficiency

Earnings Waterfall
Dongkook Pharmaceutical Co Ltd

Revenue
789.1B KRW
Cost of Revenue
-350B KRW
Gross Profit
439.1B KRW
Operating Expenses
-355.8B KRW
Operating Income
83.2B KRW
Other Expenses
-21.6B KRW
Net Income
61.7B KRW

Free Cash Flow Analysis
Dongkook Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dongkook Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
55/100
Profitability
Score

Dongkook Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dongkook Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
80/100
Solvency
Score

Dongkook Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

Lowest
Price Target
23 230 KRW
39% Upside
Average
Price Target
26 010 KRW
56% Upside
Highest
Price Target
29 400 KRW
76% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Dongkook Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dongkook Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Dongkook Pharmaceutical Co Ltd stock?

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is 19 388.02 KRW.

Is Dongkook Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 16 710 KRW, Dongkook Pharmaceutical Co Ltd is Undervalued by 14%.

Back to Top